|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||43.70 - 43.70|
|52-week range||43.70 - 43.70|
|Beta (5Y monthly)||0.64|
|PE ratio (TTM)||16.55|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Juan López-Belmonte Encina became the CEO of Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI) in 2017. This report...
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
A week ago, Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI) came out with a strong set of full-year numbers that...